Arrhythmias & electrophysiology

Comparison of the ATRIA, CHADS 2 , and CHA 2 DS 2 -VASc stroke risk scores in predicting ischaemic stroke in a large Swedish cohort of patients with atrial fibrillation

Eur Heart JPublished Retrospective cohort study

Authors' conclusion

In this SAF cohort, the ATRIA score predicted ischaemic stroke risk better than CHADS2 or CHA2DS2-VASc.

Study context

Population
Swedish patients hospitalized or visiting a hospital-based outpatient clinic with atrial fibrillation (AF), not receiving warfarin, July 2005–December 2010not receiving warfarin
Participants
152,153 patients
Exposure
ATRIA vs CHADS2 vs CHA2DS2-VASc stroke risk scores
Outcome
Prediction of acute ischaemic stroke (C-index, NRI)
Methodological detailsnational cohort, nationwide registry, Variables determined from comprehensive national databases
  • National cohort
  • Nationwide registry
  • Variables determined from comprehensive national databases

Main finding

As reported in the abstract

Ischaemic stroke prediction, C-index (entire point scores)

Net reclassification improvement (NRI)

0.16

CI 0.14–0.17

ATRIA vs CHADS2

NRI

0.21

CI 0.20–0.23

ATRIA vs CHA2DS2-VASc

ATRIA

0.708

C-index · CI 0.704–0.713

CHADS2

0.690

C-index · CI 0.685–0.695

CHA2DS2-VASc

0.694

C-index · CI 0.690–0.700

Observational data: associations, not effects.

Further findings

Acute ischaemic stroke incidence

Acute ischaemic strokes observed
11 053
Mean stroke rate (vs 2%/year in California cohorts)
3.2%/year

C-index with published low/moderate/high risk cut-points

C deteriorated but ATRIA remained superior

NRI with cut-points altered to fit cohort stroke rates

NRI decreased

Original publication

Comparison of the ATRIA, CHADS 2 , and CHA 2 DS 2 -VASc stroke risk scores in predicting ischaemic stroke in a large Swedish cohort of patients with atrial fibrillation. Eur Heart J. Published 3 March 2016. doi:10.1093/eurheartj/ehw077

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.